Cargando…
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines update – IV – A quality appraisal with the AGREE II instrument
BACKGROUND: Since the publication of The World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines in 2010, a number of other guidelines, expert opinions, and position papers relating to the management of cow's milk allergy (CMA) hav...
Autores principales: | Stróżyk, Agata, Ruszczyński, Marek, Horvath, Andrea, Dahdah, Lamia, Fiocchi, Alessandro, Nowak-Węgrzyn, Anna, Shamir, Raanan, Spergel, Jonathan, Vandenplas, Yvan, Venter, Carina, Szajewska, Hania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419447/ https://www.ncbi.nlm.nih.gov/pubmed/36091188 http://dx.doi.org/10.1016/j.waojou.2021.100613 |
Ejemplares similares
-
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update – VII – Milk elimination and reintroduction in the diagnostic process of cow's milk allergy
por: Meyer, Rosan, et al.
Publicado: (2023) -
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XIII – Oral immunotherapy for CMA – Systematic review
por: Bognanni, Antonio, et al.
Publicado: (2022) -
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update – X – Breastfeeding a baby with cow's milk allergy
por: McWilliam, Vicki, et al.
Publicado: (2023) -
Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - III - Cow's milk allergens and mechanisms triggering immune activation
por: Jensen, Sebastian A., et al.
Publicado: (2022) -
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy
por: Brozek, Jan L., et al.
Publicado: (2022)